abstract |
The present invention relates to novel derivatives of 3-hydroxyanthranilic acid of general formula (I), methods for their preparation, novel pharmaceutical compositions and the use thereof for inhibiting the enzyme 3-hydroxyanthranilate oxygenase, 3-HAO, responsible for the production of the endogenous neurotoxin quinolinic acid, QUIN. |